Month: March 2025

COLLEGEVILLE, Pa., March 07, 2025 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, today announced that Charterfield Landing is now open for sale in Collegeville, Pennsylvania. This new community showcases an exclusive selection of expansive home sites with thoughtfully designed open-concept floor plans featuring side-entry garages and basements, as well as sophisticated options for personalization. The Sales Center and model home are now open at 4037 MacCormack Way in Collegeville. “Charterfield Landing provides home buyers with the opportunity to experience luxury living in a peaceful and picturesque setting,” said John Dean, Division President of Toll Brothers in Pennsylvania. “The community’s desirable blend of comfort and convenience, along with its proximity to upscale shopping...

Kaldalón hf. will publish its financial results and trading updates as per the following schedule:Annual General Meeting April 3, 2025Q1 2025 Trading update May 19, 2025H1 2025 Half-year Results August 21, 2025Q3 2025 Trading update November 17, 2025Management statement 2025 February 12, 2026Approved statements 2025 March 4, 2026Annual General Meeting 2025 March 26, 2026All financial information will be released after market close. Please note that the dates are subject to change. For further information, please contact:Jón Þór Gunnarsson, CEO of Kaldalón hf.Email: jon.gunnarsson@kaldalon.is

Maranello (Italy), March 7, 2025 – Ferrari N.V. (NYSE/EXM: RACE) (“Ferrari” or the “Company”) informs that, following the accelerated bookbuild offering made by Exor N.V. on February 26, 2025, the Company participated in the offering by purchasing No. 666,666 common shares for a total consideration of 299,999,700 Euro (the “Transaction”). The Transaction constituted the seventh tranche (the “Seventh Tranche”) of the multi-year share buyback program of approximately Euro 2.0 billion announced during our 2022 Capital Market Day (the ”Program”) and it settled on March 3, 2025. As of March 6, 2025, following the completion of the Seventh Tranche, the Company held in treasury No. 15,785,877 common shares equal to 8.73% of the total issued share capital including the common shares and the special voting shares, net of shares assigned under...

Includes one Extended Timeline Pool Offering Targeting Smaller Investors MCLEAN, Va., March 07, 2025 (GLOBE NEWSWIRE) — Freddie Mac (OTCQB: FMCC) announced today it will offer approximately $290 million in non-performing loans (NPL) for sale via auction. The NPLs being offered consist of seasoned, deeply delinquent residential first lien whole loans held in Freddie Mac’s mortgage-related investments portfolio. The NPLs are currently serviced by Select Portfolio Servicing Inc., Newrez LLC, d/b/a Shellpoint Mortgage Servicing or Nationstar Mortgage LLC, d/b/a Rushmore Servicing. The NPLs are being marketed via four pools: three Standard Pool Offerings (SPO®) and one Extended Timeline Pool Offering (EXPO®), which targets participation by smaller investors, including non-profits and Minority, Women, Disabled, LGBTQ+, Veteran or Service-Disabled...

REYKJAVIK, Iceland, March 07, 2025 (GLOBE NEWSWIRE) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today its participation in Barclays 27th Annual Global Healthcare Conference, which will be held in Miami, Florida on March 11-13, 2025. Robert Wessman, founder, chairman and CEO and members of the management team will host one-on-one meetings. Alvotech will also be participating in a fireside chat on Wednesday, March 12, 2025, at 9:30-9:55 am EDT (13:30-13:55 GMT). An audio webcast of the fireside chat will also be available to investors and the general public and can be accessed in the Events Section of Alvotech’s Investor Portal. After the event, a recording will also be available for 90 days. About AlvotechAlvotech is...

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today its participation in Barclays 27th Annual Global Healthcare Conference, which will be held in Miami, Florida on March 11-13, 2025. Robert Wessman, founder, chairman and CEO and members of the management team will host one-on-one meetings. Alvotech will also be participating in a fireside chat on Wednesday, March 12, 2025, at 9:30-9:55 am EDT (13:30-13:55 GMT). An audio webcast of the fireside chat will also be available to investors and the general public and can be accessed in the Events Section of Alvotech’s Investor Portal. After the event, a recording will also be available for 90 days. About AlvotechAlvotech is a biotech company, founded by Robert Wessman, focused solely...

Owner of TCL Chinese Theatre and Dolby Theatre to Provide Strategic Guidance, Expanding Access to Premier Industry Venues and Relationships LOS ANGELES, March 07, 2025 (GLOBE NEWSWIRE) — Stargaze Entertainment Group Inc. (“Stargaze” or the “Company”) (OTC: STGZ), a content creation and social platform designed to redefine talent discovery, has appointed renowned film producer and entertainment mogul Elie Samaha to its Advisory Board. This addition is set to strengthen Stargaze’s industry influence and expand opportunities for emerging talent. As a key public figure in Hollywood, Samaha’s ownership of two of the most iconic venues in entertainment provides Stargaze with unprecedented access to industry-defining spaces, including the TCL Chinese Theatre, a historic movie palace on the Hollywood Walk of Fame, and the Dolby Theatre,...